# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001615219-17-000016
Filing Date
2017-02-23
Accepted
2017-02-23 08:42:38
Documents
3
Period of Report
2017-02-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | a20170222form8-k.htm | 8-K | 27579
2 | EXHIBIT 99.1 | actrimsposter2017final.htm | EX-99.1 | 15949
3 |  | actrimsposter2017final001.jpg | GRAPHIC | 1887671
| Complete submission text file | 0001615219-17-000016.txt |  | 2644753

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 17630835
SIC: 2834 Pharmaceutical Preparations